Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity

Sponsor
McMaster University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05992571
Collaborator
Alzheimer's Society of Brant, Haldimand Norfolk, Hamilton Halton (Other)
30
2
11

Study Details

Study Description

Brief Summary

People who report subjective memory complaints have a greater risk of developing dementia. Memory issues may be an early warning sign of dysfunctional cerebral glucose metabolism and cerebral blood flow. Interventions that can restore cerebral metabolism and enhance cerebral blood flow may protect against conversion to dementia. Exogenous ketone supplements have been shown rapidly improves brain network function in young adults. Further, infusion studies demonstrate that ketone bodies enhance cerebral blood flow in cognitively normal adults. Whether acute ketone monoester supplementation can improve brain function in adults with subjective memory complaints is currently unknown.

This study will investigate the effects of a single ketone monoester dose on resting-state functional connectivity in the default mode network and resting cerebral blood flow in adults with subjective memory complaints.

Condition or Disease Intervention/Treatment Phase
  • Other: Placebo
  • Dietary Supplement: β-OHB
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
A randomized double-blind placebo-controlled crossover design will be used to test two conditions. Participants will consume 60 mL of: 1) a drink containing a ketone monoester supplement ([R]-3-hydroxybutyl [R]-3-hydroxybutyrate; 0.3 g β-OHB/kg body weight); and 2) a taste-matched calorie-free inert placebo drink.A randomized double-blind placebo-controlled crossover design will be used to test two conditions. Participants will consume 60 mL of: 1) a drink containing a ketone monoester supplement ([R]-3-hydroxybutyl [R]-3-hydroxybutyrate; 0.3 g β-OHB/kg body weight); and 2) a taste-matched calorie-free inert placebo drink.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Impact of Acute Oral Ketone Monoester Supplementation on Resting-state Brain Connectivity in Adults With Memory Complaints
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo

Single dose of a taste-matched calorie-free placebo

Other: Placebo
Ingestion of a taste-matched calorie-free placebo drink followed by 90 minutes of rest.

Experimental: β-OHB

Single dose of a ketone monoester ([R]-3-hydroxybutyl [R]-3-hydroxybutyrate; 0.6 g β-OHB/kg body weight)

Dietary Supplement: β-OHB
Ingestion of a high dose [R]-3-hydroxybutyl [R]-3-hydroxybutyrate (0.6 g β-OHB/kg body weight) followed by 90 minutes of rest.

Outcome Measures

Primary Outcome Measures

  1. Brain network connectivity [90 minutes]

    Functional connectivity of the default mode network (DMN) is measured via functional MRI. Changes in BOLD signal in each region are determined by independent component analysis and then functional connectivity is measured as a Pearson correlation (r) between the neural regions comprising the DMN and transformed into a z score.

  2. Cerebral blood flow [90 minutes]

    Sum of blood flow in the internal carotid and vertebral arteries via phase contrast MRI in ml/min.

Secondary Outcome Measures

  1. Working memory [90 minutes]

    Computer battery to assess working memory (n-back test) based on N2 reaction time

  2. Executive function [90 minutes]

    Computer battery to assess executive function (Stroop test) based on Stroop Cost (reaction times to incongruent stimuli minus congruent stimuli).

  3. Attention and working memory [90 minutes]

    Computer battery to assess working memory (digit symbol substitution task) based on the number of correct responses in 120 seconds.

Other Outcome Measures

  1. Mean arterial pressure [90 minutes]

    Automated blood pressure cuff measurement of brachial artery pressure in mmHg.

  2. Plasma beta-hydroxybutyrate [90 minutes]

    Measured via finger capillary samples in mM

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • between the ages of 55 and 70

  • presence of subjective memory complaints as determined by the Prospective- Retrospective Memory Questionnaire

  • cognitively normal, e.g. score ≥26 on the Montreal Cognitive Assessment

Exclusion Criteria:
  • Presence of obesity (body mass index > 30 kg/m^2)

  • Presence of known cardiovascular disease

  • Presence of type 2 diabetes

  • History of cardiovascular events requiring hospitalization (e.g., heart attack, stroke)

  • History of concussion(s) with persistent symptoms

  • Currently following a ketogenic diet and/or taking ketone body supplements

  • Diagnosis of any form of Alzheimer's disease or dementia

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • McMaster University
  • Alzheimer's Society of Brant, Haldimand Norfolk, Hamilton Halton

Investigators

  • Principal Investigator: Jeremy Walsh, PhD, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeremy Walsh, Assistant Professor, McMaster University
ClinicalTrials.gov Identifier:
NCT05992571
Other Study ID Numbers:
  • rs-KME
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jeremy Walsh, Assistant Professor, McMaster University

Study Results

No Results Posted as of Aug 15, 2023